ChemoMetec ( CPH:CHEMM ) First Half 2023 Results Key Financial Results Revenue: kr.242.7m (up 16% from 1H 2022). Net...
Alternatively, email editorial-team (at) simplywallst.com. Simply Wall St has no position in any stocks mentioned. This article by Simply Wall St is general in nature. [View the Free Analysis](https://simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-chemm/chemometec-shares/valuation) - EPS: kr.6.06 (up from kr.4.90 in 1H 2022). [CPH:CHEMM](https://simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-chemm/chemometec-shares)) First Half 2023 Results